Sharma Sanchit, Agarwal Samagra, Saraya Anoop
Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):774-782. doi: 10.1016/j.jceh.2023.04.008. Epub 2023 Apr 29.
Limited data exist on strategies other than hepatic venous pressure gradient (HVPG) estimation to predict future events in patients with cirrhosis presenting with variceal bleed (VB) but are otherwise compensated. We assessed whether liver stiffness measurement (LSM) during VB episode could accurately predict this risk.
Consecutive patients with cirrhosis with VB as their index decompensation event underwent HVPG and LSM estimation during the VB episode in this prospective study. New onset further decompensation events (ascites, VB, encephalopathy) was assessed over follow-up. The performance characteristics of postbleed LSM were compared with model for end stage liver disease (MELD) score and HVPG to predict future decompensation and were cross-validated.
Mean age of the cohort (n = 68) was 44.2 years and alcohol-related liver disease (55.9%) was the most common etiology. Over a median follow-up of 14 (9-18) months, 18(26.4%) patients developed further decompensation with ascites being the most common event. Patients with further decompensation had a higher median postbleed LSM [60.5 kPa (53-70) vs. 25 kPa (18-34), < 0.001], HVPG [ 19 mm Hg vs. 16 mmHg, = 0.005], and MELD score [ 12.5 (11-14.7) vs. 10 (8-12) < 0.001]. The area under receiver-operator characteristics curve for postbleed LSM [0.928 (95%CI: 0.868-0.988)] was higher than both HVPG [0.733(0.601-0.865), = 0.003] and MELD score [0.776(0.664-0.889), = 0.019] to predict further decompensation. Optimism-corrected c-statistic using MELD and postbleed LSM was similar to a combination of HVPG, MELD, and postbleed LSM.
Postbleed LSM is comparable to HVPG estimation in predicting further decompensation events in patients with otherwise compensated cirrhosis presenting with VB.
除肝静脉压力梯度(HVPG)评估外,关于预测静脉曲张破裂出血(VB)但病情得到代偿的肝硬化患者未来事件的策略,现有数据有限。我们评估了VB发作期间的肝脏硬度测量(LSM)是否能准确预测这种风险。
在这项前瞻性研究中,以VB作为首次失代偿事件的肝硬化连续患者在VB发作期间接受了HVPG和LSM评估。在随访期间评估新发的进一步失代偿事件(腹水、VB、肝性脑病)。将出血后LSM的性能特征与终末期肝病模型(MELD)评分和HVPG进行比较,以预测未来失代偿情况,并进行交叉验证。
该队列(n = 68)的平均年龄为44.2岁,酒精性肝病(55.9%)是最常见的病因。在中位随访14(9 - 18)个月期间,18名(26.4%)患者出现了进一步失代偿,腹水是最常见的事件。出现进一步失代偿的患者出血后LSM的中位数更高[60.5 kPa(53 - 70)对25 kPa(18 - 34),P < 0.001],HVPG[19 mmHg对16 mmHg,P = 0.005],以及MELD评分[12.5(11 - 14.7)对10(8 - 12),P < 0.001]。出血后LSM的受试者工作特征曲线下面积[0.928(95%CI:0.868 - 0.988)]高于HVPG[0.733(0.601 - 0.865),P = 0.003]和MELD评分[0.776(0.664 - 0.889),P = 0.019],用于预测进一步失代偿。使用MELD和出血后LSM的乐观校正c统计量与HVPG、MELD和出血后LSM的组合相似。
在预测以VB为表现且病情得到代偿的肝硬化患者的进一步失代偿事件方面,出血后LSM与HVPG评估相当。